Name: Medicinal Chemistry 2023
Start: 2023-10-04
End: 2023-10-06
Location: India

Conference Information

Welcoming Message

Medicinal Chemistry 2023 welcomes chemical professionals, researchers, professors, scientific communities, delegates, students, business professionals, and executives from all over the world to attend the “3rd International Meeting and Expo on Medicinal Chemistry and Pharmaceutical Science” which is to be held during October 02-04, 2023 in Vienna, Austria which includes prompt Keynote presentations, Oral talks, Poster presentations, and Exhibitions.

The Conference aims to serve as a forum for international researchers from various fields of chemistry, pharmacy, medicinal chemistry, and drug design by offering a platform for critical evaluation of innovative design and sharing the most recent, cutting-edge research findings and results regarding all aspects of medicinal chemistry. The current chemistry conference will feature significant topics such as medicinal chemistry, pharmaceutical sciences, drug design and development, drug chemistry, and general applications. It will also be a global gathering.

This conference is a place where people can come together to build, learn and recreate things for the better and lead a healthy life. At this meeting, good ideology and methodology have a strong chance to become reality.

It would be an excellent arena for showcasing your research about drug design and networking with peers and eminent figures.

About Conference

We are happy to extend an invitation to all researchers and leaders to join us at the “3rd International Meeting and Expo on Medicinal Chemistry and Pharmaceutical Science”, which will be held in Vienna, Austria from October 02-04, 2023. This is on behalf of the organizing committee of Medicinal Chemistry 2023. All qualified candidates are encouraged to apply, including medicinal chemists, professors, directors/deans, associate professors, faculty, students, and post-medicinal chemistry scholars.

The meeting program combines feature speakers, video presentations, banner introductions, and posters. Oral communications from junior to postdoctoral scientists will also be included.

In light of this topic, the gathering course of action aims to provide a conversation to general researchers from various fields of Medicinal Chemistry and Drug Design and development by giving a phase to the essential examination of new arranging, and to share the most recent advancements in research discoveries and results in nearly all areas of therapeutic science.

Join us for the three fascinating days of the conference, which will include all-hands meetings, feature meetings, oral and banner introductions, displays, and much more so you may learn and share your involvement in research.

Young Scientist Benefits:

Oral presentations about medicinal chemistry at our conferences offer the best platform for your research.
Sharing ideas with mentors and prominent scholars.
The winners of the Young Scientist Award will receive certificates from pharmaceutical science meetings and mementos.
Through this Forum, young scientists will receive pertinent and current information.
Platform for young researchers to collaborate for improved development.
Award should encourage participants to work hard to reach their maximum potential, which might benefit the industry as a whole.

Target Audience:

Assistant Professors and Associate in Pharmaceutical sciences and Medicinal Chemistry
Researchers and Post-doctoral in pharmaceutical sciences and Medicinal Chemistry
Laboratory Chemists
Chemical Scientists working on Pharmaceutical Chemistry
A wide variety of markets are expanding in the fields of medicinal chemistry and chemistry, respectively.
Graduates and Post Graduates in pharmaceutical sciences and Medicinal Chemistry
Experts in the development of Medicinal Chemistry and Drug Chemistry
Professors in pharmaceutical sciences and Medicinal Chemistry
Heads of Pharmaceutical sciences and Medicinal Chemistry Departments

Scientific Sessions/Tracks

Session on: Applied Medicinal Chemistry

Small organic compounds are the primary focus of applied medicinal chemistry. To find and create new therapeutic agents, applied medicinal chemistry combines computational chemistry, natural product medicinal chemistry, and synthetic organic medicinal chemistry closely with chemical biology, enzymology, and structural biology.

Subjects:

Adrenergic Drugs
Anticancer Drugs
Antihistamines and Local Anaesthetics
Cardiovascular Drugs
Psychoactive Drugs

Related Conferences:

Related Associations:

European Federation for Medicinal Chemistry | Asian Federation for Medicinal Chemistry | Chinese Pharmaceutical Association | European Federation for Pharmaceutical Sciences | International Chemical Biology Society | International Union of Pure and Applied Chemistry

Associated Journals:

Associated Societies:

Session on: Anti-Infective Agents

The goal of Anti-Infective Agents in Medicinal Chemistry is to cover all the most recent and noteworthy advancements in medicinal chemistry and rational drug development for the creation of new anti-infective agents. Each issue includes several timely in-depth reviews on a variety of current subjects in anti-infective medicinal chemistry, published by experts in the field. Every medicinal chemist who wants to be in for medicinal chemistry about the most recent and significant advancements in the creation of anti-infective drugs should subscribe to Anti-Infective Agents in Medicinal Chemistry.

Subjects:

Cephalosporins
Erythromycin and other macrolides
Tetracyclines
Nitrofurans and drugs for urinary tract infections
Aminoglycosides

Related Conferences:

Related Associations:

Associated Journals:

Associated Societies:

Session on: Vaccines and Antibiotics

Strong drugs that combat bacterial illnesses are antibiotics. The majority of antibiotics belong to one of several antibiotic classes. A class of antibiotics is a collection of several medications with comparable pharmacologic and chemical characteristics. A few classes of antibiotics include penicillin, tetracycline, cephalosporin, quinolones, lincomycin, macrolides, sulphonamides, aminoglycosides, and carbapenems. A few antibiotics function by eradicating bacteria (bacteria or parasites). This is frequently accomplished by messing with the bacterial or parasitic cell wall's structure. Some work by preventing the parasite or bacteria from proliferating.

Subjects:

Inactivated vaccines
Live-attenuated vaccines
Messenger RNA (mRNA) vaccines
Bacteriostatic
Aminoglycosides

Related Conferences:

Related Associations:

Associated Journals:

Associated Societies:

Session on: Drug Chemistry

Clinical pharmaceutical care principles and a medical team with deep knowledge and experience in infectious diseases and the use of antimicrobial agents can help clinicians execute their tasks more logically while protecting the efficacy of some vital medications from MDR diffusion. We believe that by employing research techniques from the 1800s to 1900s in the absence of many bureaucratic regulations, we can produce more pertinent pharmacological compounds for use in modern medicinal chemistry.

Subjects:

Pharmaceutical Formulations
Formulation Research and Development
Industrial Pharmacy
Drug Formulation Procedures
Biomarkers in Drug Design

Related Conferences:

Related Associations:

Associated Journals:

Associated Societies:

Session on: Pharmacovigilance

Pharmacovigilance practices, or GVP as they are abbreviated, allow for the measurement and presentation of pharmacovigilance. The goal of GVP and pharmacoepidemiology in risk management is to emphasize a drug's positive effects above its negative ones. Companies that offer pharmacovigilance services and scientific trials must be certified. Focusing on the signal investigation through observational studies to comprehend safety signals is of high rank.

Subjects:

Food and Drug Administration
Health Care Personnel
Adverse Drug Reaction.
Vaccine Efficacy
European Medicines Agency

Related Conferences:

Related Associations:

Associated Journals:

Associated Societies:

Session on: Nutraceuticals

This term, which combines the words "nutrition" and "pharmaceutical" is used to refer to all organic food elements with potential health advantages. Nutraceuticals are a growing field in the pharmaceutical industry where goods (drugs) are made from food sources, thereby providing consumers with additional health benefits and enhancing their nutritional status. The products that come from the nutraceutical industry aid in keeping the human body healthy, regulating any signs of illnesses that may have developed in the past, and preventing the system from developing any malignant processes.

Subjects:

Dietary Supplements
Functional Foods
Nutraceuticals-Production and Sales
Medicinal foods
Health Benefits of Nutraceuticals

Related Conferences:

Related Associations:

Associated Journals:

Associated Societies:

Session on: Proteomics

Because proteins are the main agents of medication action, proteome research has the potential to play a role in observing how proteins change in response to drug administration. It can be applied to nearly every situation in the pharmaceutical business, such as target identification and validation, the development of biomarkers for efficacy and toxicity, and investigations into the mechanisms underlying drug action or chemo-resistance. Pharmacoproteomic allows the test subject to receive large concentrations of experimental medicinal chemistry over time. Serum samples will be collected to do further proteome analyses.

Subjects:

Sequence And Structural Proteomics
Expression Proteomics
Interaction Proteomics
Functional Proteomics
Identify The Subcellular Location

Related Conferences:

Related Associations:

Associated Journals:

Associated Societies:

Session on: Biomarkers in drug design

Thanks to advancements in cancer molecular characterization, researchers have been able to identify a growing number of crucial molecular drivers of cancer growth. Indian Society for Clinical Organization, Tech Association of British Pharmaceutical Industry These drug discoveries have led to the development of several cutting-edge anticancer medicinal chemistry as well as advancements in science in particular patient populations. Despite this, research is currently being done to identify clinically significant response biomarkers. In this review, we cover methods for cancer molecular characterization and the function of biomarkers in the drug design of novel anticancer therapies.

Subjects:

Neurological Biomarkers
Immunological Biomarkers
Digital Biomarkers
Cardiovascular Biomarker
Molecular Biomarkers

Related Conferences:

Related Associations:

Associated Journals:

Associated Societies:

Session on: Radiopharmaceuticals

Radioactive substances are employed in radiopharmaceuticals to identify or treat a specific illness condition. The use of radioactive agents for treating any condition may seem complicated and could harm the system, but they are thought to be safe when used in small doses for diagnostic purposes. When used for treatment, however, a larger dose of radioactive materials is required, which can have long-term negative effects on the body.

Subjects:

Diagnostic Radiopharmaceuticals
Radionuclide Generator
Radiopharmaceutical preparation
Kit for Radiopharmaceuticals
Radiopharmaceutical precursor

Related Conferences:

Related Associations:

Associated Journals:

Associated Societies:

Session on: Pharmacodynamics

Pharmacodynamics, which covers ideas like receptor binding, post-receptor effects, and chemical interactions, is the study of the biochemical, physiologic, and molecular effects of medications on the human body. The second two branches that make up the scientific field of pharmacology are the study of pharmacodynamics. It is a quantitative study of how drug exposure relates to the drug's pharmacologic and side effects. The term "pharmacodynamics" describes the connection between drug concentration at the site of action and the impact that follows, including the progression and potency of both therapeutic and unfavorable effects.

Subjects:

Drug Concentration and Effect
Pharmacodynamics of Antimicrobial Drugs
Signal Transduction and Drug Action
Drug Dose and Clinical Response
Agonists and Antagonists

Related Conferences:

Related Associations:

Associated Journals:

Associated Societies:

Session on: Biologic Drugs in Autoimmune Diseases

By using innovative, primarily biological sedates rather than material particles, significant progress has been made in the treatment of immune system diseases by drug design. Therapeutic biologic agents are those that have biologically developed. The majority of these drugs are based on antibodies or receptor proteins. Multiple sclerosis, lupus erythematosus, rheumatoid arthritis, Grave's disease, and inflammatory bowel disease can all be treated with biological.

Subjects:

Rheumatoid Arthritis (RA) Treatment
Tumor necrosis factor (TNF) inhibitors
Interleukin (IL) inhibitors
Psoriatic Arthritis Treatment
Non-steroidal anti-inflammatory drugs

Related Conferences:

Related Associations:

Associated Journals:

Associated Societies:

Session on: Clinical Research and Statistics

Investigating intentional medical behavior, weighing the relative merits of effective treatments, and identifying the best action combinations are all part of clinical investigation. Questions like "should a person with glandular cancer undergo, radical ablation or radiation or wait, and see?" are addressed by clinical analysis. In terms of preventing and minimizing biases, confounding variables, and measurement irregularities, numbers play a very important part in every aspect of style, conduct, analysis, and reporting.

Subjects:

Electronic Health Records
Genomic Medicine
Healthcare Reform & the ACA
Pharmacoepidemiology
Biotherapeutic Delivery
Bio medicinal Discovery

Related Conferences:

Related Associations:

Associated Journals:

Associated Societies:

Session on: Clinical Trials on Various Disorders

Clinical trials are merely research that is carried out in a clinical investigation. A complex network of pharmaceutical companies, venues, research labs, and educational institutions make up the clinical investigation technique. Every clinical study has a plan of action or a method for managing the trial. Clinical research produces information on effectiveness and safety. Types of disorders and the results of their clinical tests are discussed in this track.

Subjects:

Prevention trials
Screening trials
Case-control studies
Complexity of Trials
New drugs

Related Conferences:

Related Associations:

Associated Journals:

Associated Societies:

Session on: Drug-related problems in healthcare

Pharmacotherapy has been linked to undesirable health outcomes including side effects, interactions, adherence issues, cognitive decline, falls, urine incontinence, and metabolic or nutritional issues. The likelihood of these issues rises as the number of medications used. 40% of persons over the age of 65 use more than four or five drugs, which is referred to as polypharmacy.

Subjects:

Diagnosis process
Dose-related (Augmented)
Failure Therapy
Side effects and Adverse effects
Pharmacological actions of the drug

Related Conferences:

Related Associations:

Associated Journals:

Associated Societies:

Session on: Pharmacognosy

The long-established pharmaceutical science of pharmacognosy has played a variety of roles in the identification, production, and institutionalization of these drugs. Since people from the general population in developed countries have shifted to the use of homemade remedies for the self-medication of minor illnesses, the necessity of this training-related examination and instruction has increased. However, many phytomedicines need to have their clinical efficacy well examined in advance, while others need to have their possible health risks or interactions with prescription medications thoroughly investigated.

Subjects:

Pharmacokinetics
Pharmacodynamics
Develop Synthetic Biosimilars
Origin Of Drugs
Natural Products Chemistry

Related Conferences:

Related Associations:

Associated Journals:

Associated Societies:

Session on: Phytochemistry

Phytochemistry plays a fundamental role in how plants defend themselves against various pathogenic microbes by displaying an antimicrobial effect by obstructing or executing processes. From plant to plant, the amount of these mixtures released varies; some produce more and some produce less. They can occasionally be dangerous and occasionally be incredibly helpful.

Subjects:

Flavonoids
Pharmacological Activity
Medicinal Plant
Toxicity
Phytochemical

Related Conferences:

Related Associations:

Associated Journals:

Associated Societies:

Session on: Pharmaceutical Market Access

Despite the fact that the average cost of bringing a pharmaceutical product to market has risen to US$2 billion1, 36% of all new launches in the US fall short of expectations. One of the key factors in determining the success or failure of a product launch is the market access strategy and execution, which refers to a life sciences company's capacity to provide clinical and economic evidence, negotiate with stakeholders in the health care access industry3, and enable affordable and prompt product fulfilment for the right patients.

Subjects:

General medicine
Oncology
High-volume specialty
Vaccines
Rare disease

Related Conferences:

Related Associations:

Associated Journals:

Associated Societies:

Participation / Presentation Option

Oral presentation: Topics from studies, theories, professions, or privacy practices of medicinal chemistry may be briefly covered in oral presentations. People with personal experience are welcome to share their stories or personal experiences that can benefit others in their daily lives. Keynote speakers should aim to speak for 40–45 minutes, while speakers in 30-minute slots should plan to speak for 20–25 minutes. The session chair will use the remaining time for questions and discussion.

Workshop: The content of the talk will be the same for workshop presenters as it is for oral presenters about drug design and medicinal chemistry, but with more refined techniques and thorough demonstration. A workshop presentation typically lasts between 45 and 50 minutes. With special group registration exemptions, interested participants can attend the workshop with their teams and present it to their research coordinators.

Poster presentation: The Medicinal Chemistry 2023 conference will host a student poster competition to encourage current students and recent graduates to share their original research about drug design and medicinal chemistry. Including questions & answers, presenters will have roughly 5-7 minutes to present their poster. During the presentation evaluation, judges may ask questions. Young scientists get the chance to learn about the most recent discoveries made by their peers, which will help them become better transdisciplinary researchers. Hard copy displays of posters will be 1x1 M long.

Webinar: The webinar session is intended for interested participants who are unable to attend life due to scheduling difficulties or other commitments. This option allows the presenter to record their talk, which will then be played back during the webinar presentation session.

E-Poster: The webinar presentation is comparable to the e-Poster. Their presentation in this session will be made available as a poster on the conference website, and the presenter abstract will appear in the conference journal and souvenir with a DOI.

Exhibition: Pharmaceutical companies, clinical trial sites, management consultants, chemists, pharmacists, business delegates, and equipment makers are a few of the organizations that have the opportunity to exhibit goods and services at Medicinal Chemistry 2023.

Visit WHY TO EXHIBIT WITH US? to learn more about exhibitor booth information and advantages.

Abstract Submission Criteria & Eligibility

PRESENTATION REQUIREMENTS:

The registration and travel expenses are the responsibility of the presenting authors.

NOTE: Those whose abstracts are approved will receive an acceptance letter.

Participants at the conference will get conference booklets and abstract compilations.

Any presenter who is unable to attend should make arrangements for the paper/poster in question to be presented by another qualified person. If such a change is required, kindly let our conference staff know.

SUBMISSION OPTIONS:

Oral paper presentations will be given in 30-minute increments and organized into sessions based on themes. A 5-minute Q&A period will follow each of the following time slots: 45 minutes for the keynote address, 60 minutes for workshops and special sessions, and 60 minutes for the symposium.

Abstracts for poster and e-poster presentations may be submitted by graduate and master's students.

Ph.D. candidates are eligible to submit their abstracts under the specific categories for e-posters and posters shown at the Young Researchers' Forum.

NOTICE: The YRF category also includes brief oral presentations, particularly for Ph.D. candidates.

Extended abstract: The abstract template should be used for submissions. The papers that are submitted under this area may be novel empirical research, theoretical advancements, reviews, or criticisms.

Why should you attend?

Learn and share through Interactive Sessions and Workshops:

Workshops and interactive sessions encourage active discussion between speakers and attendees about a concept or practical application of a technique. These interactive sessions may be held as a panel, a staged dialogue, or a debate, all of which involve active participation from the audience. You will be able to share and present research to your peers from across the world through a range of sessions, keynote speeches, symposiums, seminars, and poster presentations.

Meet your subject matter experts:

You will be guided in current research and development by subject matter experts. They help you with research queries and content, identify the objectives, and ensure your research is scientifically acceptable.

The collaborative efforts of specialists from a wide range of professional fields, from chemo informaticians and physical chemists to atomic scholars and pharmacologists, have helped the medicinal chemistry area grow swiftly and become one that is quite fascinating. Future therapeutic medicinal chemistry provides a common forum for discussion and debate for this constantly growing and distinctive group. The journal presents benchmarks in pharmaceutical research and development and emphasizes the master examination of cutting-edge studies, from the distinct verification of targets to the disclosure, design, blend, and evaluation of bioactive experts. When important, pledges in fields as diverse as biotechnology, enzymology, green medicinal chemistry, genomics, immunology, materials science, neglected infections and stray medications, pharmacogenomics, proteomics, and toxicology are overly effectively empowered.

Networking and round table discussion session created especially for Medicinal Chemistry 2023 brings together clinicians, healthcare workers, and patients who are on the front lines of healthcare to share knowledge, create professional connections, and collaborate.

Market Analysis

For investors, the Medicinal Chemistry Systems Market Report is a useful resource. The Medicinal Chemistry Market Report covers the demand and supply information, revenue, past and present costs, and growth of the global Medicinal Chemistry Systems Industry.

The collaborative efforts of specialists from a wide range of professional fields, from chemo informaticians and physical chemists to atomic scholars and pharmacologists, have helped the medicinal chemistry area grow swiftly and become one that is quite fascinating. Future therapeutic chemistry provides a common forum for discussion and debate for this constantly growing and distinctive group. The journal presents benchmarks in pharmaceutical research and development and emphasizes the master examination of cutting-edge studies, from the distinct verification of targets to the disclosure, design, blend, and evaluation of bioactive experts. When important, pledges in fields as diverse as biotechnology, enzymology, green chemistry, genomics, immunology, materials science, neglected infections and stray medications, pharmacogenomics, proteomics, and toxicology are overly effectively empowered.

In the estimated period from 2018 to 2025, the global excipients market is projected to grow from USD 6.17 billion in 2017 to USD 9.78 billion by 2025, at a CAGR of 5.93%.

• A CAGR of 5.8% is predicted for the global chemical excipients market, which will grow from USD 6.9 billion in 2019 to USD 9.7 billion in 2025.

• At a CAGR of 5.92%, the global chemistry market is expected to grow from USD 5.71 billion in 2016 to USD 9.04 billion in 2024. (Nitty gritty investigation of the showcase CAGR is given within the report).

With rising R&D expenses and longer entry times into the market, the industry's efficiency has declined during the past ten years. Remedial science is defined as an ardent science developed for beneficial goals to encompass a broad range of topics related to isolating verification, blending, and slow progress.

This research has progressed from restorative researchers who focused on the point or pathway of medicine as a crucial concern and course of elaborate science-driven methods to the current age of combinatorial science-based high-throughput screening (HTS) libraries based on many crucial abilities over enormous medicines such as systems.

Due to the high rate of wear and tear in pre-clinical and somber upgrading checks taking into account past tactics. This action was necessary. Although the fundamental work of beneficial researchers in medicinal chemistry hasn't advanced fully in a while, computational tools, manufactured materials, and their opportunity or ejection points of view have advanced significantly.

The various methods of restorative research include silicon display, structure-based medication arrangement (SBDD), near sub-atomic field examination, and 3D QSAR procedure. The part-based sedate arrangement stands out, particularly because of the liberal advancements in testing and execution. Planning a generous medication that is both assured and reasonable in a variety of communities is one of the most difficult aspects of medication discovery. The many types of pharmaceutical planning include structure-based pharmaceutical, common item-based medication setup, part-based pharmaceutical plan, planned variety-arranged union, and chemogenomic.

3^rd International Meeting & Expo on
Medicinal Chemistry and Pharmaceutical Science

Quick Links

Theme: Adorning your Health Better & Giving your Health a new lift

Conference Information

Welcoming Message

About Conference

Scientific Sessions/Tracks

Session on: Applied Medicinal Chemistry

Session on: Anti-Infective Agents

Session on: Vaccines and Antibiotics

Session on: Drug Chemistry

Session on: Pharmacovigilance

Session on: Nutraceuticals

Session on: Proteomics

Session on: Biomarkers in drug design

Session on: Radiopharmaceuticals

Session on: Pharmacodynamics

Session on: Biologic Drugs in Autoimmune Diseases

Session on: Clinical Research and Statistics

Session on: Clinical Trials on Various Disorders

Session on: Drug-related problems in healthcare

Session on: Pharmacognosy

Session on: Phytochemistry

Session on: Pharmaceutical Market Access

Participation / Presentation Option

Abstract Submission Criteria & Eligibility

Why should you attend?

Market Analysis